Financhill
Sell
38

MRSN Quote, Financials, Valuation and Earnings

Last price:
$0.37
Seasonality move :
-5.16%
Day range:
$0.35 - $0.37
52-week range:
$0.26 - $2.83
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.31x
P/B ratio:
57.95x
Volume:
2.6M
Avg. volume:
2.8M
1-year change:
-84.87%
Market cap:
$44.9M
Revenue:
$40.5M
EPS (TTM):
-$0.59

MRSN Analysts' Consensus Rating

The 9 analysts providing 12-month price projections for Mersana Therapeutics shares anticipate an average target of $4.29, ranging from a low estimate of $1.00 to a high estimate of $10.00. This average target implies a growth of 1090.48% compared to the current stock price of $0.36.

Consensus Price Target

$4.29

Highest Price Target

$10.00

Lowest Price Target

$1.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 8 0 8

Hold 2 0 1

Sell 0 0 0
Consensus Buy -- Buy

MRSN Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Tesla Stock Overvalued or a Buy for the Next Decade?
Is Tesla Stock Overvalued or a Buy for the Next Decade?

Shares of EV major Tesla (NASDAQ:TSLA) have experienced extreme volatility…

Is Apple Stock Undervalued or Overvalued?
Is Apple Stock Undervalued or Overvalued?

For many years, Apple (NASDAQ:AAPL) was just about the perfect…

Where Will Palo Alto Networks Stock Be in 5 Years?
Where Will Palo Alto Networks Stock Be in 5 Years?

You know those companies that just refuse to slow down…

Stock Ideas

Buy
70
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Buy
68
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Buy
58
TNXP alert for May 28

Tonix Pharmaceuticals Holding [TNXP] is up 1.57% over the past day.

Sell
37
ATS alert for May 28

ATS [ATS] is down 1.27% over the past day.

Buy
88
SMR alert for May 28

NuScale Power [SMR] is down 0.37% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock